At Medicure, our mission is to serve patients by delivering safe and efficacious life-changing medicines. We are focused on improving the heart health of patients by offering a growing portfolio of cardiovascular products and ensuring all patients get access to therapy. Our commitment to service, partnership and integrity is what sets us apart.

The product information provided below is intended for residents of the U.S. only. To report an adverse event or a product complaint, or to request information about our products, please visit our Drug Safety or Medical Information pages.

AGGRASTAT (tirofiban hydrochloride) for injection

Following approval of a new dosing regimen in 2013, AGGRASTAT is the most widely used glycoprotein inhibitor in the United States. See Aggrastat Patents.

Full Prescribing Information

Aggrastat Page

ZYPITAMAG (pitavastatin) tablets

ZYPITAMAG is a statin (HMG-CoA reductase inhibitor) medication approved by the U.S. Food and Drug Administration (FDA) in July 2017. See Zypitamag Patents.

Full Prescribing Information

Zypitamag Patient Website

Zypitamag Healthcare Professionals Website